Free Trial

Semper Paratus Acquisition (LGSTW) Competitors

$0.04 0.00 (-0.25%)
As of 05/29/2026

LGSTW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Semper Paratus Acquisition stock or one of its competitors? MarketBeat compares Semper Paratus Acquisition with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Semper Paratus Acquisition include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Semper Paratus Acquisition compare to Ainos?

Semper Paratus Acquisition (NASDAQ:LGSTW) and Ainos (NASDAQ:AIMDW) are both pharmaceutical products companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, media sentiment, institutional ownership and valuation.

In the previous week, Ainos had 2 more articles in the media than Semper Paratus Acquisition. MarketBeat recorded 2 mentions for Ainos and 0 mentions for Semper Paratus Acquisition. Ainos' average media sentiment score of 0.44 beat Semper Paratus Acquisition's score of 0.00 indicating that Ainos is being referred to more favorably in the news media.

Company Overall Sentiment
Semper Paratus Acquisition Neutral
Ainos Neutral

Company Net Margins Return on Equity Return on Assets
Semper Paratus AcquisitionN/A N/A N/A
Ainos N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Semper Paratus AcquisitionN/AN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

Summary

Ainos beats Semper Paratus Acquisition on 3 of the 3 factors compared between the two stocks.

How does Semper Paratus Acquisition compare to Alvotech?

Semper Paratus Acquisition (NASDAQ:LGSTW) and Alvotech (NASDAQ:ALVOW) are both pharmaceutical products companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership, media sentiment and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Semper Paratus AcquisitionN/AN/AN/AN/AN/A
Alvotech$586.32MN/AN/AN/AN/A

In the previous week, Alvotech had 2 more articles in the media than Semper Paratus Acquisition. MarketBeat recorded 2 mentions for Alvotech and 0 mentions for Semper Paratus Acquisition. Alvotech's average media sentiment score of 1.44 beat Semper Paratus Acquisition's score of 0.00 indicating that Alvotech is being referred to more favorably in the news media.

Company Overall Sentiment
Semper Paratus Acquisition Neutral
Alvotech Positive

Company Net Margins Return on Equity Return on Assets
Semper Paratus AcquisitionN/A N/A N/A
Alvotech N/A N/A N/A

Summary

Alvotech beats Semper Paratus Acquisition on 3 of the 3 factors compared between the two stocks.

How does Semper Paratus Acquisition compare to Aravive?

Semper Paratus Acquisition (NASDAQ:LGSTW) and Aravive (NASDAQ:ARAV) are both pharmaceutical products companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

In the previous week, Semper Paratus Acquisition's average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company Overall Sentiment
Semper Paratus Acquisition Neutral
Aravive Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Semper Paratus AcquisitionN/AN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

Company Net Margins Return on Equity Return on Assets
Semper Paratus AcquisitionN/A N/A N/A
Aravive N/A N/A N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Aravive beats Semper Paratus Acquisition on 2 of the 2 factors compared between the two stocks.

How does Semper Paratus Acquisition compare to Atlantic Coastal Acquisition Corp. II?

Semper Paratus Acquisition (NASDAQ:LGSTW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both financial services companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Semper Paratus AcquisitionN/AN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

In the previous week, Semper Paratus Acquisition's average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
Semper Paratus Acquisition Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Company Net Margins Return on Equity Return on Assets
Semper Paratus AcquisitionN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

Summary

Semper Paratus Acquisition and Atlantic Coastal Acquisition Corp. II tied by winning 0 of the 0 factors compared between the two stocks.

How does Semper Paratus Acquisition compare to Biofrontera?

Semper Paratus Acquisition (NASDAQ:LGSTW) and Biofrontera (NASDAQ:BFRIW) are both pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, valuation, earnings, institutional ownership and dividends.

In the previous week, Biofrontera had 2 more articles in the media than Semper Paratus Acquisition. MarketBeat recorded 2 mentions for Biofrontera and 0 mentions for Semper Paratus Acquisition. Biofrontera's average media sentiment score of 0.43 beat Semper Paratus Acquisition's score of 0.00 indicating that Biofrontera is being referred to more favorably in the news media.

Company Overall Sentiment
Semper Paratus Acquisition Neutral
Biofrontera Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Semper Paratus AcquisitionN/AN/AN/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Semper Paratus AcquisitionN/A N/A N/A
Biofrontera N/A N/A N/A

Summary

Biofrontera beats Semper Paratus Acquisition on 3 of the 3 factors compared between the two stocks.

Get Semper Paratus Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for LGSTW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LGSTW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LGSTW vs. The Competition

MetricSemper Paratus AcquisitionShell Companies IndustryFinancial SectorNASDAQ Exchange
Market CapN/A$143.18M$5.79B$30.05B
Dividend YieldN/A5.35%5.21%5.33%
P/E RatioN/A0.9516.1326.26
Price / SalesN/A1,148.201,031.34116.86
Price / CashN/A164.5294.7356.84
Price / BookN/A42.306.487.30
Net IncomeN/A-$131.69M$1.14B$337.27M
7 Day PerformanceN/A3.40%1.08%3.58%
1 Month PerformanceN/A5.97%2.84%5.71%
1 Year PerformanceN/A18.35%20.48%39.70%

Semper Paratus Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LGSTW
Semper Paratus Acquisition
N/A$0.04
-0.3%
N/A-24.0%$0.00N/AN/A3
AIMDW
Ainos
N/A$0.13
+116.7%
N/A-21.5%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.18
-5.1%
N/A-88.0%$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat
N/AN/A$0.00N/AN/A15

Related Companies and Tools


This page (NASDAQ:LGSTW) was last updated on 5/31/2026 by MarketBeat.com Staff.
From Our Partners